{
     "PMID": "27743026",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20170920",
     "LR": "20171116",
     "IS": "1432-0533 (Electronic) 0001-6322 (Linking)",
     "VI": "132",
     "IP": "6",
     "DP": "2016 Dec",
     "TI": "Soluble phospho-tau from Alzheimer's disease hippocampus drives microglial degeneration.",
     "PG": "897-916",
     "AB": "The role of microglial cells in the development and progression of Alzheimer's disease (AD) has not been elucidated. Here, we demonstrated the existence of a weak microglial response in human AD hippocampus which is in contrast to the massive microglial activation observed in APP-based models. Most importantly, microglial cells displayed a prominent degenerative profile (dentate gyrus > CA3 > CA1 > parahippocampal gyrus), including fragmented and dystrophic processes with spheroids, a reduced numerical density, and a significant decrease in the area of surveillance (\"microglial domain\"). Consequently, there was a substantial decline in the area covered by microglia which may compromise immune protection and, therefore, neuronal survival. In vitro experiments demonstrated that soluble fractions (extracellular/cytosolic) from AD hippocampi were toxic for microglial cells. This toxicity was abolished by AT8 and/or AT100 immunodepletion, validating that soluble phospho-tau was the toxic agent. These results were reproduced using soluble fractions from phospho-tau-positive Thy-tau22 hippocampi. Cultured microglial cells were not viable following phagocytosis of SH-SY5Y cells expressing soluble intracellular phospho-tau. Because the phagocytic capacity of microglial cells is highly induced by apoptotic signals in the affected neurons, we postulate that accumulation of intraneuronal soluble phospho-tau might trigger microglial degeneration in the AD hippocampus. This microglial vulnerability in AD pathology provides new insights into the immunological mechanisms underlying the disease progression and highlights the need to improve or develop new animal models, as the current models do not mimic the microglial pathology observed in the hippocampus of AD patients.",
     "FAU": [
          "Sanchez-Mejias, Elisabeth",
          "Navarro, Victoria",
          "Jimenez, Sebastian",
          "Sanchez-Mico, Maria",
          "Sanchez-Varo, Raquel",
          "Nunez-Diaz, Cristina",
          "Trujillo-Estrada, Laura",
          "Davila, Jose Carlos",
          "Vizuete, Marisa",
          "Gutierrez, Antonia",
          "Vitorica, Javier"
     ],
     "AU": [
          "Sanchez-Mejias E",
          "Navarro V",
          "Jimenez S",
          "Sanchez-Mico M",
          "Sanchez-Varo R",
          "Nunez-Diaz C",
          "Trujillo-Estrada L",
          "Davila JC",
          "Vizuete M",
          "Gutierrez A",
          "Vitorica J"
     ],
     "AD": "Departamento Biologia Celular, Genetica y Fisiologia, Facultad de Ciencias, Instituto de Biomedicina de Malaga (IBIMA), Universidad de Malaga, Campus de Teatinos s/n, 29071, Malaga, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Departamento Bioquimica y Biologia Molecular, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain. Instituto de Biomedicina de Sevilla (IBiS)-Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, C/Prof. Garcia Gonzalez 2, 41012, Sevilla, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Departamento Bioquimica y Biologia Molecular, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain. Instituto de Biomedicina de Sevilla (IBiS)-Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, C/Prof. Garcia Gonzalez 2, 41012, Sevilla, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Departamento Bioquimica y Biologia Molecular, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain. Instituto de Biomedicina de Sevilla (IBiS)-Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, C/Prof. Garcia Gonzalez 2, 41012, Sevilla, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Departamento Biologia Celular, Genetica y Fisiologia, Facultad de Ciencias, Instituto de Biomedicina de Malaga (IBIMA), Universidad de Malaga, Campus de Teatinos s/n, 29071, Malaga, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Departamento Biologia Celular, Genetica y Fisiologia, Facultad de Ciencias, Instituto de Biomedicina de Malaga (IBIMA), Universidad de Malaga, Campus de Teatinos s/n, 29071, Malaga, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Departamento Biologia Celular, Genetica y Fisiologia, Facultad de Ciencias, Instituto de Biomedicina de Malaga (IBIMA), Universidad de Malaga, Campus de Teatinos s/n, 29071, Malaga, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Departamento Biologia Celular, Genetica y Fisiologia, Facultad de Ciencias, Instituto de Biomedicina de Malaga (IBIMA), Universidad de Malaga, Campus de Teatinos s/n, 29071, Malaga, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Departamento Bioquimica y Biologia Molecular, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain. Instituto de Biomedicina de Sevilla (IBiS)-Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, C/Prof. Garcia Gonzalez 2, 41012, Sevilla, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Departamento Biologia Celular, Genetica y Fisiologia, Facultad de Ciencias, Instituto de Biomedicina de Malaga (IBIMA), Universidad de Malaga, Campus de Teatinos s/n, 29071, Malaga, Spain. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. Departamento Bioquimica y Biologia Molecular, Facultad de Farmacia, Universidad de Sevilla, Sevilla, Spain. vitorica@us.es. Instituto de Biomedicina de Sevilla (IBiS)-Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, C/Prof. Garcia Gonzalez 2, 41012, Sevilla, Spain. vitorica@us.es. Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. vitorica@us.es.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20161014",
     "PL": "Germany",
     "TA": "Acta Neuropathol",
     "JT": "Acta neuropathologica",
     "JID": "0412041",
     "RN": [
          "0 (AIF1 protein, human)",
          "0 (Amyloid beta-Protein Precursor)",
          "0 (Antigens, CD)",
          "0 (Antigens, Differentiation, Myelomonocytic)",
          "0 (CD68 antigen, human)",
          "0 (DNA-Binding Proteins)",
          "0 (P2RY12 protein, human)",
          "0 (Presenilin-1)",
          "0 (Receptors, Purinergic P2Y12)",
          "0 (tau Proteins)",
          "EC 3.1.3.48 (Leukocyte Common Antigens)"
     ],
     "SB": "IM",
     "MH": [
          "Adult",
          "Aged",
          "Aged, 80 and over",
          "Alzheimer Disease/diagnostic imaging/genetics/*pathology",
          "Amyloid beta-Protein Precursor/genetics/metabolism",
          "Animals",
          "Antigens, CD/metabolism",
          "Antigens, Differentiation, Myelomonocytic/metabolism",
          "Apoptosis/genetics",
          "Cells, Cultured",
          "DNA-Binding Proteins/metabolism",
          "Disease Progression",
          "Female",
          "Gene Expression Regulation/genetics",
          "Hippocampus/*pathology",
          "Humans",
          "Leukocyte Common Antigens/metabolism",
          "Male",
          "Mice",
          "Mice, Transgenic",
          "Microglia/*metabolism/pathology",
          "Middle Aged",
          "Presenilin-1/genetics/metabolism",
          "Receptors, Purinergic P2Y12/metabolism",
          "tau Proteins/*metabolism"
     ],
     "PMC": "PMC5106501",
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Alzheimer",
          "Hippocampus",
          "Human brain",
          "Microglia",
          "Pathology"
     ],
     "COIS": [
          "The authors declare that they have no conflicts of interest."
     ],
     "EDAT": "2016/10/16 06:00",
     "MHDA": "2017/09/21 06:00",
     "CRDT": [
          "2016/10/16 06:00"
     ],
     "PHST": [
          "2016/07/28 00:00 [received]",
          "2016/10/05 00:00 [accepted]",
          "2016/10/05 00:00 [revised]",
          "2016/10/16 06:00 [pubmed]",
          "2017/09/21 06:00 [medline]",
          "2016/10/16 06:00 [entrez]"
     ],
     "AID": [
          "10.1007/s00401-016-1630-5 [doi]",
          "10.1007/s00401-016-1630-5 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Acta Neuropathol. 2016 Dec;132(6):897-916. doi: 10.1007/s00401-016-1630-5. Epub 2016 Oct 14.",
     "term": "hippocampus"
}